#Vaccines

Merck's Story: How an '$11 Billion by 2030' Promise Quietly Disappeared

For nearly three years, Merck insisted nothing had changed about Gardasil's $11 billion 2030 target. Then a Chinese distributor's inventory glut forced a formal withdrawal — in a single earnings call.